ROYCE & ASSOCIATES LP - EMERGENT BIOSOLUTIONS INC ownership

EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 352 filers reported holding EMERGENT BIOSOLUTIONS INC in Q4 2020. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYCE & ASSOCIATES LP ownership history of EMERGENT BIOSOLUTIONS INC
ValueSharesWeighting
Q1 2022$7,336,000
-4.4%
178,676
+1.2%
0.06%
+8.8%
Q4 2021$7,675,000
-35.0%
176,556
-25.1%
0.06%
-35.2%
Q3 2021$11,808,000
-20.2%
235,831
+0.4%
0.09%
-13.7%
Q2 2021$14,796,000
-32.9%
234,890
-1.0%
0.10%
-31.1%
Q1 2021$22,035,000
+34.0%
237,161
+29.2%
0.15%
+8.8%
Q4 2020$16,449,000
+37.8%
183,582
+58.9%
0.14%
+5.4%
Q3 2020$11,941,000
-15.6%
115,565
-35.4%
0.13%
-17.3%
Q2 2020$14,155,000
+21.7%
178,994
-10.9%
0.16%
-1.3%
Q1 2020$11,630,000
-32.0%
200,994
-36.6%
0.16%
+3.3%
Q4 2019$17,098,000
+9.2%
316,927
+5.8%
0.15%
+5.5%
Q3 2019$15,658,000
+34.6%
299,508
+24.3%
0.14%
+38.1%
Q2 2019$11,636,000
+3982.8%
240,864
+4175.2%
0.10%
+5150.0%
Q1 2019$285,000
+670.3%
5,634
+907.9%
0.00%
Q3 2018$37,000
+105.6%
559
+53.6%
0.00%
Q2 2018$18,000
+63.6%
364
+71.7%
0.00%
Q1 2018$11,0000.0%212
-8.6%
0.00%
Q4 2017$11,000
+10.0%
232
-10.1%
0.00%
Q3 2017$10,000
-97.7%
258
-99.2%
0.00%
-100.0%
Q2 2013$438,00030,3860.00%
Other shareholders
EMERGENT BIOSOLUTIONS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Broadfin Capital, LLC 2,080,519$44,336,0004.65%
GREAT POINT PARTNERS LLC 290,000$6,180,0002.65%
FIDUCIARY MANAGEMENT ASSOCIATES LLC 651,884$13,892,0000.99%
Matarin Capital Management, LLC 85,003$1,811,414,0000.83%
KINGDON CAPITAL MANAGEMENT, L.L.C. 407,000$8,673,0000.39%
ICON ADVISERS INC/CO 258,478$5,508,0000.32%
RMB Capital Management, LLC 178,204$3,798,0000.23%
NEW AMSTERDAM PARTNERS LLC/NY 159,470$3,398,0000.23%
GLOBEFLEX CAPITAL L P 94,016$2,003,0000.23%
Convergence Investment Partners, LLC 58,672$1,250,0000.17%
View complete list of EMERGENT BIOSOLUTIONS INC shareholders